Komori
Vital Ksk Holdings (3151) · RiskMitigated

Licenses, Permits and Regulations under the Act on Pharmaceuticals and Medical Devices and Other Applicable Laws

First written in FY2016. 3 of 5 entries say "Restated". Latest entry: FY2020.

5entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20192016: 120162017: 120172018: 120182019: 120192020: 12020
Same theme, other companies
Regulatory and licensing continuity risk in the pharmaceutical and long-term care businessesA theme 25 companies write about · 25 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2021: 2 of 14 companies on the "Worse" side.

0 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 25 companies compared. The sentences above are computed from all 25.
Full recordFilings, disclosures and news, newest first
  1. FY2020MitigatedAnnual report

    「Our group has established a compliance charter, provides thorough employee training and works to ensure compliance with laws and regulations.」

    The compliance charter and employee training addressing legal and licensing risks are clearly described.
  2. FY2019RestatedAnnual report

    「The Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices and Other Products (the Pharmaceuticals and Medical Devices Act), together with related laws and regulations, requires the registration and designation of licenses and permits, as well as various approvals and permits relating to development, manufacturing and imports.」

    The risk that licensing, permitting and regulatory requirements under the Pharmaceuticals and Medical Devices Act and other laws could affect performance remains in place.
  3. FY2018RestatedAnnual report

    「The Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices and Other Products (the Pharmaceuticals and Medical Devices Act), together with related laws and regulations, requires the registration and designation of licenses and permits, as well as various approvals and permits relating to development, manufacturing and imports.」

    The possibility that licensing, permitting and regulatory requirements under the Pharmaceuticals and Medical Devices Act and other laws could affect operating results is reiterated.
  4. FY2017RestatedAnnual report

    「In conducting business activities, the Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices and Other Products (the Pharmaceuticals and Medical Devices Act), together with related laws and regulations, requires the registration and designation of licenses and permits, as well as various approvals and permits relating to development, manufacturing and imports.」

    The possibility that licensing, permitting and regulatory requirements under the Pharmaceuticals and Medical Devices Act and other laws could affect operating results is reiterated.
  5. FY2016First statedAnnual report

    「In conducting business activities, the Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices and Other Products (the Pharmaceuticals and Medical Devices Act), together with related laws and regulations, requires the registration and designation of licenses and permits, as well as various approvals and permits relating to development, manufacturing and imports.」

    The status of licenses, permits and regulatory authorities could affect operating results.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Vital Ksk Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.